These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8430399)

  • 21. Preserving cardiovascular benefits of hormone replacement therapy.
    Bush TL
    J Reprod Med; 2000 Mar; 45(3 Suppl):259-73. PubMed ID: 10756507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hormone replacement therapy and cardiovascular risk in menopausal women].
    Simon T; Jaillon P
    Arch Mal Coeur Vaiss; 2001 Feb; 94(2):132-8. PubMed ID: 11265551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hormone replacement in postmenopausal women with coronary heart disease. Results and clinical consequences from recent studies].
    Schurz RA; Benzer W
    Wien Klin Wochenschr; 1997; 109 Suppl 2():42-5. PubMed ID: 9340923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Questioning the cardioprotective action of hormone replacement therapy in postmenopausal women.
    Mascitelli L; Goldstein MR; Pezzetta F
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):657-8. PubMed ID: 19424079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
    Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B
    Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone replacement therapy and cardiovascular disease.
    Samsioe G
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():23-9. PubMed ID: 8499956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cardiovascular disease as a current threat of older women. Relation to estrogens].
    Zárate A; Saucedo R; Basurto L; Martínez C
    Ginecol Obstet Mex; 2007 May; 75(5):286-92. PubMed ID: 17849811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma lipids, lipoprotein Lp(a), apolipoproteins, and hemostatic risk factors distributions in postmenopausal women.
    Cubrilo-Turek M; Stavljenić-Rukavina A; Reiner Z; Zrinski R
    Acta Med Croatica; 1999; 53(2):61-6. PubMed ID: 10705622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hormone replacement therapy and prevention of postmenopausal cardiovascular diseases].
    Grand A
    Ann Cardiol Angeiol (Paris); 1998; 47(7):481-7. PubMed ID: 9772970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term results of transdermal estrogen replacement therapy in cardiovascular disease-free postmenopausal females with and without hypertension.
    Modena MG; Rossi R; Muia N; Origliani G; Rombolà O; Molinari R
    G Ital Cardiol; 1998 Jun; 28(6):636-44. PubMed ID: 9672776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts].
    Motolese M
    Ital Heart J Suppl; 2003 Jul; 4(7):545-58. PubMed ID: 14558283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.
    Psaty BM; Heckbert SR; Atkins D; Siscovick DS; Koepsell TD; Wahl PW; Longstreth WT; Weiss NS; Wagner EH; Prentice R
    Arch Intern Med; 1993 Jun; 153(12):1421-7. PubMed ID: 8512434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiovascular effects of replacement hormones].
    Kornitzer M; Hindlet JY
    Rev Med Brux; 1995; 16(4):285-90. PubMed ID: 7481244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular disease, menopause, and the influence of hormone replacement therapy.
    Lobo RA
    Prog Clin Biol Res; 1989; 320():313-32. PubMed ID: 2690141
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiovascular disease and hormone replacement therapy: a review.
    Ayalon D; Pines A
    Isr J Med Sci; 1993 Oct; 29(10):660-3. PubMed ID: 8244671
    [No Abstract]   [Full Text] [Related]  

  • 38. Hormone replacement and cardiovascular risk factors.
    Zumoff B
    N Engl J Med; 1993 Sep; 329(14):1041; author reply 1042-3. PubMed ID: 8366908
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cardiovascular diseases and hormone replacement therapy in females].
    Szücs J
    Orv Hetil; 1995 Feb; 136(8 Suppl 1):455-7. PubMed ID: 7877817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uncertainty about postmenopausal estrogen. Time for action, not debate.
    Goldman L; Tosteson AN
    N Engl J Med; 1991 Sep; 325(11):800-2. PubMed ID: 1870653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.